|
|
 |
Conference dress code: Business casual
Announcing the PlasmaChem Prizes for best posters, Sunday and Monday!
$500 to each winner!
Over 250 lectures by international authorities!
Particles 2010
Medical/Biochemical Diagnostic, Pharmaceutical, and Drug Delivery Applications of Particle Technology
22-25 May 2010
Regal Sun Resort
Lake Buena Vista, Florida
 |
Courtesy Millenium Technology Prize |
Co-Sponsored by
- European Association of Pharma Biotechnology
Corporate Sponsor
Plenary Speakers
Haruma Kawaguchi (Kanagawa University, Yokohama, Japan)
Stimuli-responsive fluorescent particles
Helmuth Möhwald (Max Planck Institute for Colloids and Interfaces)
Nanocarriers with controlled release for materials and biosciences
James Adair (Pennsylvania State University)
Targeting tumors with hybrid nanoparticles
International Organizing Committee
T L. Andresen (Denmark)
J. M. Asua (Spain)
D. Burgess (USA)
K. Caldwell (Sweden)
R. Duncan (UK)
M. El-Sayed (USA)
N. Garti (Israel)
K. Johnston (USA)
H. Kawaguchi (Japan)
J. H. Kim (Korea)
S. Margel (Israel)
H. Möhwald (Germany)
|
B. Moudgil (USA)
R. Mueller (Germany)
T. Nilsen (USA)
D. Poncelet (France)
M. C. Roco (USA)
P. Rogueda (UK)
J. L. Salager (Venezuela)
S. Simoes (Portugal)
P. T. Spicer (USA)
S. Svenson (USA)
J. Texter (USA), General Chair
D. Thompson (USA)
|
Particles 2010 is an international conference examining the science, technology, and business aspects of medical/biochemical diagnostic, pharmaceutical, and
drug delivery applications of particle technology. Symposia will address diverse topics including nanoparticles, hydrogels, chemical and drug delivery,
controlled release, suspensions, inhalation, liposomes, micelles & microemulsions, characterization, gene delivery, siRNA delivery, chemical and biochemical diagnostics, separations, surface modification, critical and supercritical fluid applications, spray drying, emulsions,
and multiple emulsions. The conference targets practicing scientists, clinical research physicians, engineers,
managers, innovators, and entrepreneurs, and embraces the theme "particles for detection and treatment."
The conference format comprises 5 parallel tracks of over 250 invited and contributed oral papers. Over 100 contributed poster papers will be presented
in the two poster sessions.
Corporate Sponsor
NanoSight, Ltd.
Exhibitors
Conference Program
Speakers and Presenters
Saturday Evening, 22 May 2010
1800-1930 Opening Reception/Mixer/Exhibition
Sunday Morning, 23 May 2010
0800-0850
Session Chair: Andrew Lyon (Georgia Tech)
1. Plenary 1 - Haruma Kawaguchi (Kanagawa University)
Stimuli-responsive coloring particles
0900-1200 Parallel Sessions
A1 Nanoparticles & Hydrogels; B1 Characterization; C1 Gene & siRNA Delivery; D1 Triggered Release; E1 General Papers
1135-1200 Special Presentation: 39. Nily Dan; Interfaces Initiatives in the NSF Biology Directorate
1200-1400 Luncheon/Exhibition
Sunday Afternoon, 23 May 2010
1400-1730 Parallel Sessions
A2 Nanoparticles & Hydrogels; B2 Characterization; F1 Encapsulation & Controlled Release;
G1 Diagnostics; H1 Toxicology
1720-1745 Special Presentation: 84. Lucienne Juillerat; NanoImpactNet - An EU FP7 Network
Sunday Evening, 23 May 2010
1800-2000 Poster Session P1/Reception/Exhibition
Monday Morning, 24 May 2010
0800-0850
Session Chair: Gleb Sukhorukov (Queen Mary College)
85. Plenary 2 - Helmuth Möhwald (Max Planck Institute for Colloids and Interfaces)
Nanocarriers with controlled release for materials and biosciences
0900-1200 Parallel Sessions
A3 Nanoparticles & Hydrogels; I1 Targeting; C2 Gene & siRNA Delivery;
G2 Diagnostics & Imaging; J1 Inhalation Therapy
1200-1400 Luncheon/Exhibition
Monday Afternoon, 24 May 2010
1400-1730 Parallel Sessions
A4 Nanoparticles & Hydrogels; I2 Targeting; F2 Encapsulation & Controlled Release;
G3 Diagnostics & Imaging; H2 Toxicology
1705-1730 Special Presentation: 163. Philippe Rogueda; InForm: Integrating the Nanoscale in Formulations
Monday Evening, 24 May 2010
1800-1930 Poster Session P2/Reception/Exhibition
Tuesday Morning, 25 May 2010
0800-0850
Session Chair: Omid Farokhzad (Brigham and Women's Hospital)
164. Plenary 3 - James Adair (Pennsylvania State University)
Targeting tumors with hybrid nanoparticles
0900-1200 Parallel Sessions
A5 Nanoparticles & Hydrogels; K1 Surface Modification; L1 Vaccines;
G4 Diagnostics & Imaging
1200-1400 Luncheon/Exhibition
Tuesday Afternoon, 25 May 2010
1400-1730 Parallel Sessions
A6 Nanoparticles & Hydrogels; M1 Oral & Transdermal Delivery;
F3 Encapsulation & Controlled Release;
G5 Diagnostics & Imaging
1730 Conference Ends
Session A1 (Sunday 0900-1210) Nanoparticle & Hydrogel Synthesis
Session Chair: Todd Krauss
0900 2. Atsushi Takahara; Keynote - Characterization of liquid marbles coated with hydrophobic fluoropolymer microparticles
0930 3. Jean-Francois Berret; A versatile approach for the fabrication of magnetofluorescent nanorods
0945 4. Gan-Moog Chow; Size and interface effects of upconversion sodium yttrium fluoride (NaYF4) nano-phosphors
1010 Break
1030 5. Jesus Santamaria; Gold-silica hybrid nanoparticles for drug delivery and near-infrared hyperthermia
1055 6. Yukio Nagasaki; Nitroxyl radical-containing nanoparticles for ischemia reperfusion injury
1120 7. Alexander Couzis; Supramolecular paths for the synthesis of composite hollow particles
1145 8. Jianjun Cheng; Controlled formulation of polymeric nanoparticles for in vitro and in vivo drug delivery
1210 End of Session
Session A2 (Sunday 1400-1755) Nanoparticle & Hydrogel Synthesis
Session Chair: Sonke Svenson
1400 40. Ravi Bellamkonda; Multifunctional imaging nanocarriers for angiography and personalized medicine
1425 41. Elena Dormidontova; Nanoparticle targeting design optimization by computer simulations
1450 42. Sonke Svenson; Polymeric nanoparticles of camptothecin " Early clinical development of IT-101
1515 43. Robert O. Williams III; Formulation and characterization of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution
1540 Break
1600 44. Brian Windsor; Benefits of nanostructured compositions made by rapid freezing to drug delivery
1625 45. Artur Cavaco-Paulo; Protein based nano- and microspheres for medical applications
1640 46. Yu Huang; Specific peptide mediated nanoparticle sysnthesis
1705 47. Srinivas Sridhar; Nanoplatforms for nanomedicine
1730 48. Satoshi Sakamoto; Development of highly functionalized magnetic beads applicable to drug discovery research
1755 End of Session
Session A3 (Monday 0900-1225) Nanoparticle & Hydrogel Synthesis
Session Chair: Kui Yu
0900 86. Chuan-Jian Zhong; Keynote - Magnetic and core-shell nanoparticles for probing and delivering biomolecules
0930 87. Si Amar Dahoumane; Bio-controlled synthesis of gold nanoparticles using micro-algae as bioreactors: Control of size and shape and reaction kinetics
0945 88. Brian Amsden; BMP-6 release from stericly stabilized microspheres prepared from low melting point poly(caprolactone-co-trimethylene carbonate)
1010 Break
1030 89. Luis Brito; TLR agonists in nanoemulsions for adjuvant delivery
1055 90. Todd Krauss; Insights into synthesis of ultra-small semiconductor quantum dots
1120 91. Steve Little; Polymeric particles as a platform for biomimetic drug delivery
1145 92. Carmen Gruber-Traub; Biomimetic particles: Concept, design and applications in biotechnology and biomedicine
1210 93. Hadas Skaat; Synthesis and characterization of magnetic core-shell nanoparticles for inhibition or acceleration of insulin and amyloid-beta fibril formation
1225 End of Session
Session A4 (Monday 1400-1730) Nanoparticle & Hydrogel Synthesis
Session Chair: Heinrich Hofmann
1400 120. L. Andrew Lyon; Keynote - Designed core/shell nanogels for controlled release
1430 121. Frank Scheffold; Brushlike interactions between thermoresponsive microgel particles
1445 123. Matthew Yates; Hydrogel nanoparticles as carriers for peptides and proteins
1510 124. Paul Russo; Polypeptide-silica particles: Hierarchy in structure and function
1535 Break
1555 125. Heiko Schiffter; Biodegradable nanoparticles for drug delivery prepared by a new spray-drying process
1610 127. Afsaneh Lavasanifar; Engineered polymeric micelles for overcoming drug resistance in cancer
1635 126. Anna-Lena Kjøniksen; Thermosensitive hydroxyethylcellulose-graft-poly(N-isopropylacrylamide) nanoparticles
1650 128. Daniel Crespy; Nanparticles from miniemulsion relevant for biomedical applications with different chemistry, sizes, and shapes
1705 129. Shirui Mao; Polymeric micelles as carriers for peroral administration of hydroxycamptothecin
1730 End of Session
Session A5 (Tuesday 0900-1215) Nanoparticle & Hydrogel Synthesis
Session Chair: Hong Yang
0900 166. Horacio Cabral; Keynote - Supra-molecular structures as nanocarriers for drug delivery - Challenges to smart molecular therapy
0930 167. Ulyana Angel; Applications of sonochemically produced proteinaceous microspheres
0945 168. Nguyen TK Thanh; Recent developments in the synthesis of magnetic nanoparticles for biomedical application
1010 Break
1030 169. Kui Yu; Development of photoluminescent colloidal semiconductor nanocrystals aiming at bio-oriented applications
1055 170. Lian-Yan Wang; Preparation and application of alginate-chitosan microspheres with narrow size distribution for oral delivery of insulin
1110 171. Stephan Barcikowski; Design of individual gold nanomarker-bioconjugates by laser ablation without chemical precursors or ligand exchange
1135 172. Andreas Taubert; Multifunctional metal nanoparticles - Synthesis, self-assembly, and biological response
1200 173. Jie Wu; Preparation of uniform-sized quaternized chitosan micro- and nano-spheres by combining membrane emulsification and thermal-gelation
1215 End of Session
Session A6 (Tuesday 1400-1720) Nanoparticle & Hydrogel Synthesis
Session Chair: Horacio Cabral
1400 195. Hong Yang; Keynote - Engineered nanostructures for biological applications
1430 196. Rita El-Khouri; Continuous preparation of gold nanoparticles
1445 197. Robert DeLong; Biomolecular and stabilizing interactions of Au, MnO and ZnO nanomaterials with DNA, RNA and proteins
1510 198. Andreas Hütten; Magnetic particles: From sensor to microfluidic applications
1535 Break
1555 199. Roongnapa Suedee; Nanoparticle-on-microsphere molecularly imprinted polymers as drug delivery systems
1620 200. Tomoaki Hino; Improvement of dissolution property of poorly water soluble drugs by adsorption on the surface of curdlan particles
1635 201. Manish Arora; Biocompatible micro and nano-particles for controlled cavitation inception in water and procine blood
1650 202. Nurettin Sahiner; Post modification of hyaluronic acid based particles and composites for biomedical applications
1705 203. X. F. Zhang; Synthesis of mesoporous silica nanopartilces coupled with Fe3O4 or Fe3O4-Au cores as drug carriers
1720 End of Session
Session B1 (Sunday 0900-1210) Characterization
Session Chair: Dave Nicoli
0900 9. Bob Carr; Keynote - Simultaneous real-time multiparameter analysis of bionanoparticles in liquids
0930 10. Ian Block; Particle characterization in turbid systems using 3D cross-correlation techniques
0945 11. Mark Bumiller; Image analysis as a tool for particle characterization in the pharmaceutical industry
1010 Break
1030 12. Hilde Jans; Dynamic light scattering as a powerful tool for gold nanoparticle characterization and biomolecular binding studies
1045 13. Judith Kuntsche; Asymmetrical flow field-flow fractionation for the characterization of lipid-based colloidal formulations
1110 14. Giacomo Perfetti; X-ray tomography and image analysis as complementary methods for morphological characterization and coating thickness measurement of coated particles
1125 15. Hyonchol Kim; Non-amplified quantitative detection of target biomolecules using metal nanoparticle probe set and FE-SEM
1150 16. Byron Cheatham; In vitro hyperspectral imaging of nanoparticles in live cells
1205 17. Johannes H. Kindt; Quantitative nanoscale mapping of topography and surface mechanical properties
1220 Session Ends
Session B2 (Sunday 1400-1745) Characterization
Session Chair: Bob Carr
1400 49. David F. Nicoli; New focused-beam SPOS technology reaches below 0.15 μm for challenging particle size applications in biotechnology
1425 50. David Driscoll; Stability of injectable emulsions: Mean droplet diameter vs. the large-diameter tail
1450 51. Scott C. Brown; Tissue culture AFM probes, pleural space tribology and the pathogenesis of pneumothorax
1505 52. Mark A. Poggi; Quantifying in situ changes of nanoscale interactions using quartz crystal microbalance with dissipation monitoring
1520 53. Sam Yu; Novel techniques for nanoparticle analysis and characterization: Diagnostic, pharmaceutical and drug delivery applications
1535 Break
1555 54. Stephen Williams; New developments in magnetic field-flow fractionation for the analysis of magnetic nanoparticles
1620 55. Yoann Lefeuvre; Laser microrheology for soft materials
1635 56. Nuttawut Lewpiriyawong; Dielectrophoretic characterization and continuous separation of micro/submicron particles and cells in a PDMS-based microfluidic device with silver-PDMS electrodes
1650 57. Clemens Helmbrecht; Continuous characterization and separation of single particles by photophoresis
1705 58. Bieke Van de Broek; Thermo-optical properties of branched gold nanoparticles for hyperthermia tumor treatment
1720 59. Maria Teresa Celis; Characterization of nano-dispersions
1745 End of Session
Session C1 (Sunday 0900-1225) Gene and siRNA Delivery
Session Chair: Martin Woodle
0900 18. David H. Thompson; Keynote - Construction of a novel bioresponsive vector system based on beta-6-amino-cyclodextrins and PEG-polyvinyl alcohol)-adamantine host:guest interactions
0930 19. Yong Wang; The development of gold nanoparticles as a functional delivery system for islet transplant
0945 20. Yoshiki Katayama; New gene regulation delivery system using intracellular-responsive artificial gene regulator/gene complex for cell-specific therapy and imaging
1010 Break
1030 21. Robert J. Lee; Targeted nanoparticles for oligonucleotide delivery
1055 22. Laurence Navailles; Anionic nucleotide-lipids for in vivo DNA transfection
1120 23. Jon Preece; Nanoparticulate dual intracellularly degradable peptide vectors for gene delivery
1145 24. Yasuhiko Tabata; Nanoparticles technology to genetically manipulate the biological functions of stem cells
1210 25. John Texter; New nanofluid particles for gene delivery
1225 End of Session
Session C2 (Monday 0900-1200) Gene and siRNA Delivery
Session Chair: David Thompson
0900 101. Francesco Stellacci; Keynote - Cell membrane penetrating particles for RNA delivery
0930 102. Marc Abrams; Optimizing a lipid-based vehicle for siRNA delivery to liver
0955 103. Barbara Geusens; Flexible nanosomes (secosomes) enable efficient siRNA delivery in cultured primary skin cells and in the viable epidermis of ex vivo human skin
1020 Break
1040 104. Martin Woodle; Keynote - Tissue targeted siRNA nanoparticle therapeutics: The next "antibody"
1110 105. Chrsitopher Levins; Combinatorial synthesis of materials for nanoparticle based siRNA therapeutics
1135 106. Zheng-Rong Lu; Targeted multifunctional siRNA delivery systems
1200 End of Session
Session D1 (Sunday 0900-1225) Triggered Release
Session Chair: Thomas Andresen
0900 26. Kenji Kono; Keynote - Design of multifunctional nanovesicles for temperature-sensitive drug release and imaging
0930 27. Mark W. Grinstaff; Expansile nanoparticles: Synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system
0955 28. J. Andrew Mackay; Genetically engineered polypeptosomes
1020 Break
1040 29. Samir Mitragotri; Keynote - Red blood cell-mimetic synthetic particles
1110 30. Robin L. McCarley; Redox-responsive liposome-based delivery systems
1135 31. Jinming Gao; Micellar nanomedicine for cancer imaging and therapy
1200 32. Christophe Schatz; Engineering the surface of magnetic nanoparticles by adsorption of double hydrophilic block copolymers
1225 End of Session
Session E1 (Sunday 0900-1130) General Papers
Session Chair: Robert Delong
0900 33. John Volckens; Development of a system for direct, particle-to-cell deposition at the air-liquid interface in vitro
0925 34. Kerri-Ann Hue; Targeted extraction of hydrophobic mycotoxins using modified montmorillonite clays
0945 35. Johannes Kluge; Pharmaceutical micro- and nano-composites by supercritical CO2 extraction of emulsions
1010 Break
1035 36. Tommy Horozov; Particle assisted photolighography: Principles and applications
1050 37. Jonghwi Lee; Structures from electrohydrodynamic jetting and their assembly
1115 38. Yakov Rabinovich; Role of diffusion kinetics in capillary phenomena
1130 End of Session
Session F1 (Sunday 1400-1750) Encapsulation & Controlled Release
Session Chair: Christophe Lacroix
1400 60. Nily Dan; Keynote - Colloidosomes for cell encapsulation and drug delivery: Tailoring transport and flux
1430 61. Dennis Bong; Designed molecular recognition at the lipid-water interface
1455 62. Mads H. Clausen; Novel lipid conjugated prodrugs for sPLA2 activated liposomal drug delivery
1420 63. Atoosa Maleki; Thermoresponsive amphiphilic block copolymers for sustained release of hydrophobic pharmaceuticals
1535 Break
1555 64. Parkson L.-G. Chong; Bipolar tetraether liposomes: Physical properties and applications
1620 65. Amitav Sanyal; Colloidal microcapsules via directed slf-assembly at the liquid-liquid interface
1645 66. Elka Touitou; Drug delivery applications with ethosomes
1710 67. Jonathan R. Howse; Templated vesicle formation and propelled vesicles for enhanced delivery
1735 68. Daniel Klinger; Novel photodegradable crosslinkers for the preparation of light sensitive microgels
1750 End of Session
Session F2 (Monday 1400-1750) Encapsulation & Controlled Release
Session Chair: Kenji Kono
1400 138. Christophe Lacroix; Keynote - New in vitro intestinal fermentation models with immobilized human fecal microbiota for diet and drug assessment
1430 139. Anuj Chauhan; Extended opthalmic drug delivery from contact lens containing particles and barriers
1455 140. Erhan Altinoglu; Simultaneous near infrared diagnostic imaging and photodynamic therapy of cancer
1510 141. Shun’chi Kuroda; Bio-nanocapsules for the in vivo pinpoint delivery of nucleic acids and drugs
1535 Break
1555 142. Anja Kroeger; Functionalized and tunable nanoparticles for biomedical applications and their interactions with cells
1610 143. Wei Wei; Preparation of hierarchical hollow CaCO3 particles and their application as anticancer drug carrier
1625 144. Thomas Scheibel; Spider silk submicroparticles for controlled drug delivery
1650 145. Pilar Rivera Gil; Intracellular processing of proteins mediated by biodegradable polyelectrolyte capsules
1705 146. Guanghi Ma; Preparation of uniform-sized microspheres and microcapsules for drug delivery
1720 147. Uta Riebetanz; Cell-penetrating peptide as surface layer for fast endocytotic uptake of colloidal microcarriers by cells
1735 148. Emilia Pisani; Sustained release nanoparticles for oral administration of irinotecan
1750 End of Session
Session F3 (Tuesday 1400-1735) Encapsulation & Controlled Release
Session Chair: Thomas Scheibel
1400 211. Gleb Sukhorukov; Keynote - Intracellular delivery of polyelectrolyte capsules for on-site sensing and manipulation
1430 212. Eric Simone; Filamentous therapeutic enzyme encapsulating polymer nanocarriers
1455 213. To Ngai; Stimulus-sensitive particles at liquid interfaces: Self-assembly and stabilizing properties
1510 214. Paula Pescador; Nucleolipid-based microtubes for storage and delivery of bioactive compounds
1525 215. Kosta Ladavac; Foam-templated functional particles
1540 Break
1600 216. Frank Boury; Calcium carbonate microparticles formulated in supercritical CO2: Application for protein encapasulation
1625 217. Dara Van Gough; Size selection: Programming access to encapsulated biomolecules in mesoporous hollow spheres
1650 218. Jennifer S. Hong; Microfluidic directed assembly of liposome-hydrogel hybrid nanoparticles
1705 219. Aysegul Aygun; Stability and controlled release mechanisms of biocides encapsulated in liposomes
1720 220. Viviano Vergaro; Halloysite nanotubes and nanocolloids: High payload drug nanocarriers
1735 End of Session
Session G1 (Sunday 1400-1705) Diagnostics & Imaging
Session Chair: Shlomo Margel
1400 69. Ulrich Wiesner; Keynote - C Dots: Fluorescent core-shell silica nanoparticles for bioimaging and nanomedicine
1430 70. Clémence Sicard; Gold production by silica-entrapped photosyntheitic organisms: A "living" bio-hybrid material
1445 71. Sandra Rosenthal; Lipid rafts modulate membrane mobility of serotonin transporters in living serotonergic neurons revealed by single quantum dot
1510 72. Qun Huo; NanoDLSay for broad-based immunoassays
1535 Break
1555 73. Wolfgang Parak; Keynote - Ion sensing and delivery with nano- and microparticles
1625 74. Si-Shen Feng; Nanoparticles of biodegradable polymers for cancer detection and treatment at its earliest stage
1650 75. Eric K. Dufek; Surface enhanced Raman scattering as a readout strategy for immunodetection
1705 End of Session
Session G2 (Monday 0900-1210) Diagnostics & Imaging
Session Chair: Uhlrich Wiesner
0900 107. Heinrich Hofmann; Keynote - SPION as a diagnostic tool at the molecular level
0930 108. Lionel Maurizi; New method of SPION synthesis: In vitro and in vivo biological applications as an MRI contrast agent
0945 109. Thomas L. Andresen; Nanoparticles for in vivo imaging |
Particles 2010 Home
Program
